OBJECTIVE
To evaluate the oncologic outcomes of patients with sinonasal cancer treated with endoscopic resection.
DESIGN
Retrospective review.
SETTING
Tertiary care academic cancer center.
PATIENTS
All patients with biopsy-proved malignant neoplasm of the sinonasal region who were treated with endoscopic resection between 1992 and 2007 were included in the study, and their charts were reviewed for demographics, histopathologic findings, treatment details, and outcome.
MAIN OUTCOME MEASURES
Oncologic outcomes, including disease recurrence and survival.
RESULTS
Of a total of 120 patients, 93 (77.5%) underwent an exclusively endoscopic approach (EEA) and 27 (22.5%) underwent a cranioendoscopic approach (CEA) in which the surgical resection involved the addition of a frontal or subfrontal craniotomy to the transnasal endoscopic approach. Of the 120 patients, 41% presented with previously untreated disease, 46% presented with persistent disease that had been partially resected, and 13% presented with recurrent disease after prior treatment. The most common site of tumor origin was the nasal cavity (52%), followed by the ethmoid sinuses (28%). Approximately 10% of the tumors had an intracranial epicenter, most commonly around the olfactory groove. Tumors extended to or invaded the skull base in 20% and 11% of the patients, respectively. An intracranial epicenter (P < .001) and extension to (P = .001) or invasion of (P < .001) the skull base were significantly more common in patients treated with CEA than in those treated with EEA. The primary T stage was evenly distributed across all patients as follows: T1, 25%; T2, 25%; T3, 22%; and T4, 28%. However, the T-stage distribution was significantly different between the EEA group and the CEA group. Approximately two-thirds (63%) of the patients treated with EEA had a lower (T1-2) disease stage, while 95% of patients treated with CEA had a higher (T3-4) disease stage (P < .001). The most common tumor types were esthesioneuroblastoma (17%), sarcoma (15%), adenocarcinoma (14%), melanoma (14%), and squamous cell carcinoma (13%). Other, less common tumors included adenoid cystic carcinoma (7%), neuroendocrine carcinoma (4%), and sinonasal undifferentiated carcinoma (2%). Microscopically positive margins were reported in 15% of patients. Of the 120 patients, 50% were treated with surgery alone, 37% received postoperative radiation therapy, and 13% were treated with surgery, radiation therapy, and chemotherapy. The overall surgical complication rate was 11% for the whole group. Postoperative cerebrospinal fluid leakage occurred in 4 of 120 patients (3%) and was not significantly different between the CEA group (1 of 27 patients) and the EEA group (3 of 93 patients) (P > .99). The cerebrospinal fluid leak resolved spontaneously in 3 patients, and the fourth patient underwent successful endoscopic repair. With a mean follow-up of 37 months, 18 patients (15%) experienced local recurrence, with a local disease control of 85%. Regional and distant failure occurred as the first sign of disease recurrence in 6% and 5% of patients, respectively. The 5- and 10-year disease-specific survival rates were 87% and 80%, respectively. Disease recurrence and survival did not differ significantly between the EEA group and the CEA group.
CONCLUSIONS
To the best of our knowledge, this is the largest US series to date of patients with malignant tumors of the sinonasal tract treated with endoscopic resection. Our results suggest that, in well-selected patients and with appropriate use of adjuvant therapy, endoscopic resection of sinonasal cancer results in acceptable oncologic outcomes.
[1]
Islam R. Herzallah,et al.
Endoscopic Endonasal Resection of Esthesioneuroblastoma: A Multicenter Study
,
2009,
American journal of rhinology & allergy.
[2]
P. Levine.
Would Dr. Ogura approve of endoscopic resection of esthesioneuroblastomas? An analysis of endoscopic resection data versus that of craniofacial resection
,
2009,
The Laryngoscope.
[3]
P. Gardner,et al.
ENDOSCOPIC RECONSTRUCTION OF THE CRANIAL BASE USING A PEDICLED NASOSEPTAL FLAP
,
2008,
Neurosurgery.
[4]
P. Gardner,et al.
Endoscopic skull base surgery: Principles of endonasal oncological surgery
,
2008,
Journal of surgical oncology.
[5]
D. Lombardi,et al.
Endoscopic Surgery for Malignant Tumors of the Sinonasal Tract and Adjacent Skull Base: A 10-year Experience
,
2008,
American journal of rhinology.
[6]
D. Suki,et al.
PROGNOSTIC SIGNIFICANCE OF TRANSDURAL INVASION OF CRANIAL BASE MALIGNANCIES IN PATIENTS UNDERGOING CRANIOFACIAL RESECTION
,
2007,
Neurosurgery.
[7]
M. Bignardi,et al.
Endonasal endoscopic resection and radiotherapy in olfactory neuroblastoma: Our experience
,
2007,
Head & neck.
[8]
A. Garden,et al.
Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment.
,
2007,
International journal of radiation oncology, biology, physics.
[9]
R. Casiano,et al.
Surgical outcomes and safety of transnasal endoscopic resection for anterior skull tumors
,
2007,
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[10]
M. de Vincentiis,et al.
Endoscopic treatment of esthesioneuroblastoma: A minimally invasive approach combined with radiation therapy
,
2007,
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[11]
P. Gardner,et al.
The posterior pedicle inferior turbinate flap: a new vascularized flap for skull base reconstruction.
,
2007,
The Laryngoscope.
[12]
C. Snyderman,et al.
Endoscopic Reconstruction of Cranial Base Defects following Endonasal Skull Base Surgery.
,
2007,
Skull base : official journal of North American Skull Base Society ... [et al.].
[13]
V. Schramm,et al.
Craniofacial resection for malignant paranasal sinus tumors: Report of an International Collaborative Study
,
2005,
Head & neck.
[14]
V. Schramm,et al.
Complications of craniofacial resection for malignant tumors of the skull base: Report of an International Collaborative Study
,
2005,
Head & neck.
[15]
H. Stammberger,et al.
Combined endoscopic surgery and radiosurgery as treatment modality for olfactory neuroblastoma (esthesioneuroblastoma)
,
2005,
Acta Neurochirurgica.
[16]
M. Citardi,et al.
Endoscopic Resection of Sinonasal Malignancies: A Preliminary Report
,
2004,
American journal of rhinology.
[17]
V. Schramm,et al.
Craniofacial surgery for malignant skull base tumors
,
2003,
Cancer.
[18]
T. Calcaterra,et al.
Nasal and paranasal sinus carcinoma: Are we making progress?
,
2001,
Cancer.